Search research articles
Contact Us
Filters
Showing results (271-280 of 525) with videos related to
Page
of 53
Sort By:
The Journal of Clinical Investigation
|
October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
Pierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120
Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Frontiers in Immunology
|
January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
Tinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.
Mucosal Immunology
|
January 28, 2016
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
D Archary, K E Seaton, J S Passmore, et al.
Journal of Virology
|
February 4, 2012
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design
Mattia Bonsignori, David C Montefiori, Xueling Wu, et al.
The Journal of Experimental Medicine
|
November 12, 2020
Vi-specific serological correlates of protection for typhoid fever
Celina Jin, Jennifer Hill, Bronwyn M Gunn, et al.
Vaccine
|
January 11, 2011
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
Michael C Keefer, Sharon E Frey, Marnie Elizaga, et al.
Journal of Virology
|
March 5, 2010
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination
Stephanie A Freel, Laurie Lamoreaux, Pratip K Chattopadhyay, et al.
Nature Communications
|
July 3, 2019
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
Qifeng Han, Julia A Jones, Nathan I Nicely, et al.
JCI Insight
|
August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119
Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Page
of 53
Search research articles
Search
Showing results (271-280 of 525) with videos related to
Sort By:
Page
of 53
The Journal of Clinical Investigation
|
October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
Pierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120
Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Frontiers in Immunology
|
January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
Tinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.
Mucosal Immunology
|
January 28, 2016
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
D Archary, K E Seaton, J S Passmore, et al.
Journal of Virology
|
February 4, 2012
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design
Mattia Bonsignori, David C Montefiori, Xueling Wu, et al.
The Journal of Experimental Medicine
|
November 12, 2020
Vi-specific serological correlates of protection for typhoid fever
Celina Jin, Jennifer Hill, Bronwyn M Gunn, et al.
Vaccine
|
January 11, 2011
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
Michael C Keefer, Sharon E Frey, Marnie Elizaga, et al.
Journal of Virology
|
March 5, 2010
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination
Stephanie A Freel, Laurie Lamoreaux, Pratip K Chattopadhyay, et al.
Nature Communications
|
July 3, 2019
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
Qifeng Han, Julia A Jones, Nathan I Nicely, et al.
JCI Insight
|
August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119
Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Page
of 53